Exclusive special offer and discount title banner vector image

SOUTH KOREA MALE INFERTILITY MARKET FORECAST 2023-2030

SCOPE OF THE REPORT

South Korea Male Infertility Market by Test Type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer-assisted Semen Analysis, Sperm Penetration Assay, Other Test Types) Market by Treatment (Assisted Reproductive Technology and Surgery, Medications)


MARKET OVERVIEW

The South Korea male infertility market is predicted to reach a revenue share of $132.49 million by 2030, and is projected to grow with an 8.25% CAGR between the forecasting years 2023 and 2030.

The male infertility market in South Korea is poised for growth, driven by several key factors. Significant lifestyle changes leading to increased infertility cases, high prevalence of diseases like diabetes and cancer, and the rising use of assisted reproductive technologies (ARTs) contribute to market expansion. In 2020, the National Center for Biotechnology Information reported a substantial number of individuals with diabetes mellitus in Korea, with higher rates among males.

To Know More About This Report, Request a Free Sample Copy

Additionally, the growing incidence of cancer in men can result in infertility issues due to cancer therapies. The regional prevalence of infertility has become a clinical concern, leading to the development of cutting-edge infertility therapies offered by commercial companies and public institutions. The availability of advanced male fertility treatments, including procedures like intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), is expected to drive significant market growth. 

Furthermore, the use of traditional Korean medicine (TKM), including acupuncture and herbal medicines, offers alternative approaches for infertile men with poor semen quality. These factors collectively contribute to the anticipated rapid expansion of the male infertility market in South Korea.

The South Korea male infertility market segmentation entails the study by treatment and test type. Market by test type covers computer-assisted semen analysis, sperm agglutination, DNA fragmentation technique, sperm penetration assay, oxidative stress analysis, microscopic examination, and other test types.

Computer-assisted semen analysis (CASA) utilizes electronic imaging and advanced software to assess various properties of sperm with precision and repeatability. Compared to conventional methods, CASA systems offer ease of use and deliver accurate results. Technological advancements have propelled the growth of CASA, with improvements in imaging devices, increased computational power, and updated software algorithms. These advancements enable CASA systems to automatically capture images of hundreds to thousands of sperm in a short period, assess motility and morphology simultaneously, and store and analyze data efficiently. 

Furthermore, developing open-source CASA software like OpenCASA allows users to study multiple sperm quality parameters and analyze sperm response to stimuli, expanding its applications. With these technological advancements and software innovations, the CASA market is expected to grow significantly during the forecast period.

In contrast, the sperm penetration assay (SPA), also known as the hamster zona-free ovum test, assesses sperm’s ability to penetrate the egg’s membrane. It is commonly conducted in IVF facilities and provides valuable insights for clinicians in selecting appropriate treatment options. SPA accurately evaluates human spermatozoa’s fertilization potential with low false-negative rates, especially in severe oligozoospermia cases. It acts as a prognostic tool for making informed decisions, particularly in cases related to intracytoplasmic sperm injection (ICSI) and imprinting disease concerns. However, SPA’s reliability in predicting IVF success is limited, making it unsuitable for improving success rates.

The South Korea male infertility market has leading players like EMD Serono Inc (Merck Serono), Amgen, Bayer Group, etc.

Bayer, a global life science company headquartered in Germany, focuses on nutrition and healthcare. The company operates through pharmaceuticals, crop science, and consumer health divisions. In the crop science segment, Bayer develops, produces, and markets products for crop & seed protection and sustainable agriculture, including customer services and digital solutions. 

The pharmaceuticals division specializes in ophthalmology, women’s health, oncology, diagnostic imaging, hematology, and cardiology. The Consumer Health division offers medical items, cosmetics, nonprescription medications, and self-care solutions for pain relief, digestive health, dermatology, and allergies. Bayer has a global presence with 354 consolidated companies in 83 countries, with its headquarters in Leverkusen, Germany.

One of Bayer’s products, Menevit, is a male fertility supplement designed to support sperm health, including motility, production, testosterone levels, and overall reproductive health.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2030
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Test Type and Treatment
Countries AnalyzedSouth Korea
Companies AnalyzedAmgen, Bayer Group, EMD Serono Inc (Merck Serono), Sanofi

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. KEY GROWTH ENABLERS
    5. KEY CHALLENGES
  3. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON MALE INFERTILITY MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. GROWTH PROSPECT MAPPING – SOUTH KOREA
    5. MARKET MATURITY ANALYSIS
    6. MARKET CONCENTRATION ANALYSIS
    7. PESTLE ANALYSIS – SOUTH KOREA
  4. MARKET BY TEST TYPE
    1. DNA FRAGMENTATION TECHNIQUE
    2. OXIDATIVE STRESS ANALYSIS
    3. MICROSCOPIC EXAMINATION
    4. SPERM AGGLUTINATION
    5. COMPUTER-ASSISTED SEMEN ANALYSIS
    6. SPERM PENETRATION ASSAY
    7. OTHER TEST TYPES
  5. MARKET BY TREATMENT
    1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
    2. MEDICATIONS
  6. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES
      1. AMGEN
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      2. BAYER GROUP
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      3. EMD SERONO INC (MERCK SERONO)
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      4. SANOFI
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1:  MARKET SNAPSHOT – MALE INFERTILITY

TABLE 2:  SOUTH KOREA MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3:  SOUTH KOREA MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 4:  SOUTH KOREA MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5:  SOUTH KOREA TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 6:  SOUTH KOREA MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7:  SOUTH KOREA MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 8:  LIST OF MERGERS & ACQUISITIONS

TABLE 9:  LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 10:  LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 11:  LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1:  KEY MARKET TRENDS

FIGURE 2:  PORTER’S FIVE FORCES ANALYSIS

FIGURE 3:  GROWTH PROSPECT MAPPING 

FIGURE 4:  MARKET MATURITY ANALYSIS

FIGURE 5:  MARKET CONCENTRATION ANALYSIS

FIGURE 6:  SOUTH KOREA MALE INFERTILITY MARKET, GROWTH POTENTIAL, BY TEST TYPE, IN 2022

FIGURE 7:  SOUTH KOREA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)

FIGURE 8:  SOUTH KOREA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)

FIGURE 9:  SOUTH KOREA MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 10:  SOUTH KOREA MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2030 (IN $ MILLION)

FIGURE 11:  SOUTH KOREA MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2030 (IN $ MILLION)

FIGURE 12:  SOUTH KOREA MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 13:  SOUTH KOREA MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2030 (IN $ MILLION)

FIGURE 14:  SOUTH KOREA MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2030 (IN $ MILLION)

FIGURE 15:  SOUTH KOREA TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2022

FIGURE 16:  SOUTH KOREA MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2030 (IN $ MILLION)

FIGURE 17:  SOUTH KOREA MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2030 (IN $ MILLION)

FAQ’s